Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
ID: ALA4797661
Max Phase: Preclinical
Molecular Formula: C30H35N3O6
Molecular Weight: 533.63
Molecule Type: Unknown
Associated Items:
ID: ALA4797661
Max Phase: Preclinical
Molecular Formula: C30H35N3O6
Molecular Weight: 533.63
Molecule Type: Unknown
Associated Items:
Canonical SMILES: CC(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](CC(C)C)C(=O)c1ccco1
Standard InChI: InChI=1S/C30H35N3O6/c1-19(2)16-24(28(36)27-10-7-15-39-27)32-30(38)26(18-22-11-13-23(35)14-12-22)33-29(37)25(31-20(3)34)17-21-8-5-4-6-9-21/h4-15,19,24-26,35H,16-18H2,1-3H3,(H,31,34)(H,32,38)(H,33,37)/t24-,25-,26-/m0/s1
Standard InChI Key: GHCXNMKZVYMBND-GSDHBNRESA-N
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Unknown | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Molecular Weight: 533.63 | Molecular Weight (Monoisotopic): 533.2526 | AlogP: 3.17 | #Rotatable Bonds: 13 |
Polar Surface Area: 137.74 | Molecular Species: NEUTRAL | HBA: 6 | HBD: 4 |
#RO5 Violations: 1 | HBA (Lipinski): 9 | HBD (Lipinski): 4 | #RO5 Violations (Lipinski): 1 |
CX Acidic pKa: 9.50 | CX Basic pKa: | CX LogP: 3.24 | CX LogD: 3.24 |
Aromatic Rings: 3 | Heavy Atoms: 39 | QED Weighted: 0.25 | Np Likeness Score: -0.09 |
1. Sun Q,Zhou T,Xi D,Li X,Lü Z,Xu F,Wang C,Niu Y,Xu P. (2020) Design and synthesis of tripeptidyl furylketones as selective inhibitors against the β5 subunit of human 20S proteasome., 192 [PMID:32146375] [10.1016/j.ejmech.2020.112160] |
Source(1):